AROSIO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.011
EU - Europa 2.227
AS - Asia 1.912
SA - Sud America 279
AF - Africa 29
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.465
Nazione #
US - Stati Uniti d'America 3.901
SG - Singapore 760
CN - Cina 541
IT - Italia 442
DE - Germania 318
RU - Federazione Russa 309
SE - Svezia 255
BR - Brasile 235
HK - Hong Kong 222
IE - Irlanda 183
GB - Regno Unito 146
UA - Ucraina 128
VN - Vietnam 127
AT - Austria 87
PL - Polonia 86
CA - Canada 81
IN - India 77
FR - Francia 74
FI - Finlandia 69
TR - Turchia 38
JP - Giappone 31
BE - Belgio 30
DK - Danimarca 30
NL - Olanda 25
MX - Messico 21
AR - Argentina 19
ID - Indonesia 19
BD - Bangladesh 18
ES - Italia 18
IR - Iran 14
KR - Corea 14
IQ - Iraq 13
ZA - Sudafrica 11
EC - Ecuador 8
EG - Egitto 8
AE - Emirati Arabi Uniti 7
PK - Pakistan 6
CO - Colombia 5
LT - Lituania 5
CH - Svizzera 4
CL - Cile 4
CZ - Repubblica Ceca 4
IL - Israele 4
KZ - Kazakistan 4
PT - Portogallo 4
TW - Taiwan 4
UZ - Uzbekistan 4
JM - Giamaica 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
AU - Australia 2
BO - Bolivia 2
ET - Etiopia 2
EU - Europa 2
HN - Honduras 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
A1 - Anonimo 1
AM - Armenia 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
HU - Ungheria 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
PY - Paraguay 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 8.465
Città #
Ann Arbor 791
Singapore 499
Ashburn 341
Houston 303
Chandler 266
Woodbridge 254
Hong Kong 217
Dublin 174
Frankfurt am Main 173
Jacksonville 163
Milan 161
Dearborn 155
Wilmington 153
Fairfield 133
New York 111
Santa Clara 107
Beijing 95
Vienna 84
Princeton 72
Dallas 68
Kraków 65
Los Angeles 64
Nanjing 62
Shanghai 57
Seattle 53
Cambridge 45
Ho Chi Minh City 42
Lachine 32
Pisa 32
Brussels 30
Buffalo 29
Munich 27
São Paulo 27
Lecco 24
Shenyang 24
The Dalles 24
Guangzhou 23
Hanoi 23
Moscow 23
Dong Ket 21
Boardman 20
Fremont 20
Ottawa 17
Tianjin 17
Changsha 16
Tokyo 16
Turku 16
Jakarta 15
Nanchang 15
London 14
Pune 14
Jinan 13
Andover 12
Brooklyn 12
Hebei 12
Helsinki 12
Lawrence 12
Warsaw 12
Zhengzhou 12
San Francisco 11
Council Bluffs 10
Edmonton 10
Falls Church 10
San Diego 10
Altamura 9
Amsterdam 9
Lappeenranta 9
Manchester 9
Phoenix 9
Stockholm 9
Atlanta 8
Chennai 8
Chicago 8
Denver 8
Hefei 8
Campinas 7
Jiaxing 7
Minya 7
Montreal 7
Nuremberg 7
Rio de Janeiro 7
Torino 7
Toronto 7
Belo Horizonte 6
Cagliari 6
Düsseldorf 6
Mexico City 6
Orem 6
Rome 6
Ankara 5
Baghdad 5
Brusuglio 5
Columbus 5
Johannesburg 5
Kunming 5
New Delhi 5
Norwalk 5
Varedo 5
Wroclaw 5
Almaty 4
Totale 5.615
Nome #
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 408
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 406
Micrornas in als: from molecular mechanisms to clinical relevance 321
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 319
miR-129-5p: A key factor and therapeutic target in amyotrophic lateral sclerosis 312
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 296
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 289
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 274
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 273
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 264
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 264
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 260
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 257
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 247
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 245
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 244
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 244
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 239
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 228
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 227
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 215
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 214
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 213
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 212
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 210
BDNF serum levels with respect to multidimensional assessment in amyotrophic lateral sclerosis 208
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 208
the MonzALS collaborative network 204
ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion 203
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 191
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 188
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 179
Study of transcriptional alterations in Amyotrophic Lateral Sclerosis 174
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 171
Serum BDNF in amyotrophic lateral sclerosis decreases with disease severity 155
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 145
Totale 8.707
Categoria #
all - tutte 25.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021436 0 0 0 0 0 45 79 57 69 77 48 61
2021/2022413 29 65 45 27 31 30 14 39 25 18 35 55
2022/2023894 71 250 76 114 68 138 7 56 69 6 18 21
2023/2024614 29 26 16 23 77 188 100 27 20 17 11 80
2024/20251.421 75 172 131 47 123 57 51 65 172 239 122 167
2025/20261.846 445 139 263 434 529 36 0 0 0 0 0 0
Totale 8.707